Bioadaptives BDPT
OTC BDPT
$0.00 0.00 (-6.74%)
As of: Aug 21, 2026 · 3:59 PM EDT

Bioadaptives, Inc. (BDPT) Invested Capital (2013 - 2020)

Bioadaptives (BDPT) posted Invested Capital of $3389.0 for Q2 2020, down 53.05% sequentially from $7218.0 in Q4 2019.

Bioadaptives, Inc. (BDPT) Invested Capital (2013 - 2020) Analysis & Trends

Bioadaptives has reported Invested Capital for 6 years, with the latest figure at $3389.0 in Q2 2020.

  • Quarterly Invested Capital changed N/A year-over-year to $3389.0 in Q2 2020, while the trailing twelve-month figure through Mar 2021 was $3389.0 (down 53.05% YoY) and the FY2019 annual result came in at $7218.0, changed N/A from the prior year.
  • Invested Capital declined to $3389.0 in Q2 2020 per BDPT's latest filing, from $7218.0 in the prior quarter.
  • Over five years, Invested Capital peaked at $264474.0 in Q3 2016 and troughed at $3389.0 in Q2 2020.
  • A 3-year average of $152195.6 and a median of $232910.0 in 2016 frame the typical range for Invested Capital.
  • The widest YoY moves for Invested Capital: up 814.13% in 2016, down 119.87% in 2016.
  • Over 3 years, Invested Capital stood at $264474.0 in 2016, then slumped by 97.27% to $7218.0 in 2019, then sank by 53.05% to $3389.0 in 2020.
  • According to Business Quant data, Invested Capital over the past three periods registered $3389.0, $7218.0, and $264474.0 for Q2 2020, Q4 2019, and Q3 2016 respectively.

Peer Comparison

Historic Data

Download Data
DateValue
Jun 30, 2020 3,389.00
Dec 31, 2019 7,218.00
Sep 30, 2016 264,474.00
Jun 30, 2016 252,987.00
Mar 31, 2016 232,910.00
Dec 31, 2015 150,849.00
Sep 30, 2015 120,286.00
Jun 30, 2015 68,895.00
Mar 31, 2015 25,479.00
Dec 31, 2014 26,233.00
Jun 30, 2014 48,839.00
Mar 31, 2014 31,839.00
Dec 31, 2013 31,839.00